Artificial intelligence : identification of lung cancers with high accuracy!

 | Post date: 2022/09/19 | 
Lung cancer has one of the highest incidence rates and mortality rates among all common cancers worldwide. Early detection of suspicious lung nodules is crucial in fighting lung cancer. In recent years, with the proliferation of clinical data like low-dose computed tomography (LDCT), histology whole slide images, electronic health records, and sensor readings from medical IoT devices etc., many artificial intelligence tools have taken more important roles in lung cancer management. Artificial intelligence (AI) is good at handling a large volume of computational and repeated labor work and is suitable for assisting doctors in analyzing image-dominant diseases like lung cancer. Scientists have shown long-standing efforts to apply AI in lung cancer screening via CXR and chest CT since the 1960s. Several grand challenges were held to find the best AI model. Currently, the FDA have approved several AI programs in CXR and chest CT reading, which enables AI systems to take part in lung cancer detection. Following the success of AI application in the radiology field, AI was applied to digitalized whole slide imaging (WSI) annotation. Integrating with more information, like demographics and clinical data, the AI systems could play a role in decision-making by classifying EGFR mutations and PD-L1 expression. AI systems also help clinicians to estimate the patient’s prognosis by predicting drug response, the tumor recurrence rate after surgery, radiotherapy response, and side effects.
Read more


View: 54 Time(s)   |   Print: 4 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2022 CC BY-NC 4.0 | Modern Medical Laboratory Journal